Clinical Trials Sponsored by GlaxoSmithKline AG, Switzerland

Total 103 results

University Hospital Inselspital, Berne
Schweizerische Unfallversicherung SUVA, Switzerland; Mepha Parma AG, Switzerland and other collaborators

Terminated

Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures

Surgical Wound Infection

Switzerland
Phonak AG, Switzerland

Completed

Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids

Hearing Loss, Bilateral or Unilateral

Switzerland
Phonak AG, Switzerland

Completed

Optimization of Music Compression (OMC)

Hearing Loss

Switzerland
Phonak AG, Switzerland

Completed

Evaluation of Frequency Lowering Technique

Hearing Loss

Germany
Phonak AG, Switzerland

Completed

Real-Ear Measurement (REM) and Test Box System Integration Into Fitting Software

Validation Studies

Switzerland
Phonak AG, Switzerland

Unknown

Evaluation of New Custom Made Hearing Product Technology and Shell Modification (CPS)

Hearing Loss, Bilateral or Unilateral

Switzerland
Phonak AG, Switzerland

Completed

Post-market Study to Capture Information Regarding Performance of Lyric2

Hearing Loss

United States
University Children's Hospital Basel
Permamed AG, Switzerland; Galvita AG, Switzerland

Completed

Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions (CHILD-IVITAB)

Bioequivalence

Switzerland
iOMEDICO AG
BeiGene Switzerland GmbH

Recruiting

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma (ARIADNE)

Follicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenström's Macroglobulinemia

Germany, Austria
Northwestern University
Phonak AG, Switzerland

Completed

Remote Microphone Candidacy Study

Hearing Loss, Sensorineural

United States
University Hospital, Basel, Switzerland
Medgate AG, Switzerland; HMO Gesundheitsplan Basel, Switzerland

Completed

Telephone Triage Study

Any Medical Condition Presented by Patient

Switzerland
LimmaTech Biologics AG
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

Klebsiella Pneumoniae Infection

Germany
LimmaTech Biologics AG
GlaxoSmithKline

Recruiting

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

Recurrent Vulvovaginal Candidiasis

Belgium
University Hospital, Basel, Switzerland
Novartis Pharma AG, Basel, Switzerland

Completed

Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS® (SMARTCARE)

Multiple Sclerosis (MS)

Switzerland
Collabree AG
University Hospital, Basel, Switzerland

Recruiting

Collabree: An Intervention to Improve the Regularity of Medication Intake

Hypertension | Medication Adherence

Switzerland
University Hospital, Basel, Switzerland
greenTEG AG

Completed

Fever Tracking Study

Core Body Temperature in Healthy Subjects | Immune Response to mRNA COVID-19 Vaccination

Switzerland
University Hospital Muenster
Phonak AG, Switzerland

Unknown

The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility

Auditory Processing Disorder

Germany, Switzerland
University Hospital, Basel, Switzerland
Anaveon AG

Recruiting

ACT-TIL and ANV419 for Advanced Melanoma. (BaseTIL-03M)

Advanced Melanoma

Switzerland
University Hospital, Basel, Switzerland
Fresenius AG

Completed

BaSES Trial: Basel Starch Evaluation in Sepsis (BaSES)

Sepsis | Septic Shock | Severe Sepsis

Switzerland
Bacoba AG
University Hospital, Basel, Switzerland; Swiss TPH, Basel, Switzerland

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses

Healthy

Switzerland
ETOP IBCSG Partners Foundation
AstraZeneca AG Switzerland

Not yet recruiting

A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. (ADOPT-lung)

Non Small Cell Lung Cancer
Wings Health AG
University Hospital, Basel, Switzerland

Recruiting

Feasibility of Technology-Based SSIP in Prostate Cancer Patients

Prostate Cancer | Psychosocial Stressor

Switzerland
Haag-Streit AG
University Hospital, Basel, Switzerland

Completed

Clinical Trial ES 900 - 2019

Optical Biometry of the Human Eye | General Analysis of the Anterior Chamber of the Human Eye

Switzerland
Sensimed AG
Clinique de Montchoisi, Lausanne, Switzerland

Completed

Use of an Ocular Telemetry Sensor in Diamox Treated Patients

Ocular Hypertension | Glaucoma

Switzerland
University Hospital, Basel, Switzerland
Siemens Healthineers AG

Recruiting

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS (SPINNERS)

Stroke

Switzerland, United States
Haag-Streit AG
University Hospital, Basel, Switzerland

Completed

Clinical Trial ES 900 - 2016

Optical Biometry of the Human Eye | General Analysis of the Anterior Chamber of the Human Eye

Switzerland
Oertli Instrumente AG
University of Geneva, Switzerland

Unknown

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP (HFDS_abinterno)

Glaucoma | Cataract | POAG

Germany, Switzerland, Egypt, India
University Hospital, Basel, Switzerland
Roche Pharma AG

Completed

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

Renal Anemia

Switzerland
University Hospital, Ghent
Novartis Pharma AG, Switzerland

Completed

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

Asthma | Nasal Polyposis

Belgium
IFAG AG
Hiscia Society for Cancer Research; IFAG Basel AG, both Switzerland

Unknown

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Pancreas Cancer

Austria, Germany
iOMEDICO AG
Stemline Switzerland GmbH; Climedo Health GmbH

Recruiting

Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma - SEATTLE- (SEATTLE)

Multiple Myeloma

Austria, Germany
Claudio Gobbi
Merck AG Switzerland

Active, not recruiting

Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

Multiple Sclerosis

Switzerland
University Hospital, Basel, Switzerland
Ricola Group AG Schweiz

Completed

Effectiveness of Different Candies Against Bad Breath (HALIDROP)

Bad Breath

Switzerland
Ospedale Regionale di Locarno
Bichsel AG, Interlaken, Switzerland

Completed

Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

Haemodialysis

Switzerland
IFAG AG
Hiscia Society for Cancer Research; IFAG Basel AG (CRO), both Switzerland

Unknown

Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)

Colorectal Cancer

Austria, Germany
Medela AG
Clinical Trial Unit, University Hospital Basel, Switzerland

Completed

Influence of the Brownie Breast Shield on the Dynamics of Milk Removal (BDM)

Lactation

Switzerland
University Hospital, Basel, Switzerland
University of Basel; Aarelab AG

Completed

Vitamin B12 Acceptance and Biomarker Response Study

Vitamin B 12 Deficiency

Switzerland
Profil Institut für Stoffwechselforschung GmbH
Pendragon Medical AG Switzerland

Completed

Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method

Diabetes Mellitus

Germany
University Hospital Inselspital, Berne
PharmaPart; Viollier AG, Basel, Switzerland

Completed

Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b

Relapsing-remitting Multiple Sclerosis

Switzerland
Profil Institut für Stoffwechselforschung GmbH
Pendragon Medical AG Switzerland

Completed

Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Germany
Balgrist University Hospital
Industry (Schülke & Mayr AG, Switzerland and Germany)

Recruiting

General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery (BALGDEC)

Elective Surgery | High Risk | Prevention of Surgical Site Infections | Randomized-controlled Trial

Switzerland
Insel Gruppe AG, University Hospital Bern
University Hospital, Basel, Switzerland

Active, not recruiting

Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF (COMPARE-CRYO)

Paroxysmal Atrial Fibrillation

Switzerland
University Hospital, Basel, Switzerland
University of Basel; Solothurner Spitäler AG

Completed

Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin

Diabetes Mellitus Type 2

Switzerland
University Hospital, Basel, Switzerland
St. Claraspital AG; Clarunis - Universitäres Bauchzentrum Basel

Recruiting

Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair (ROGER-RCT)

Hernia, Inguinal | Robotic Surgical Procedures

Switzerland
Phonak AG, Switzerland
University of Toronto; Baycrest Centre for Geriatric Care

Completed

Hearing Instruments in Alzheimer's Disease (HIAD)

Alzheimer Disease | Hearing Loss

Canada
University Hospital, Basel, Switzerland
SenTec AG, Ringstrasse 39, CH-4106 Therwil

Terminated

Accuracy of Non-invasive Continuous CO2-Monitoring

Blood Gas Monitoring, Transcutaneous

Switzerland
Ulrik Lassen
GlaxoSmithKline; Pfizer; Roche Pharma AG

Recruiting

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling (ProTarget)

Neoplasms | Cancer | Tumors | Neoplasia

Denmark
McGill University
Institut Straumann AG; ITI International Team for Implantology, Switzerland

Completed

Single-implant Overdentures Retained by the Novaloc Attachment System

Edentulous Jaw | Edentulous Mouth

Canada
Swiss Federal Institute of Technology
Zuercher Hoehenklinik Wald; Hocoma AG, Switzerland

Completed

ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization (ERIGO®LIFE)

Stroke | Spinal Cord Injury

Switzerland
Universidad de Valparaiso
GlaxoSmithKline; Roche Pharma AG; Aclin Laboratory

Completed

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . (CORE-HIV)

Hepatitis B | HIV

Chile

Clinical Trials Sponsored by GlaxoSmithKline AG, Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations